Kriegsmann, K., Schöning, T., Schwarzbich, M., Cremer, M., Dittrich, T., Ho, A. D., & Witzens-Harig, M. (2016). Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma. BioMed Central; Springer.
Chicago-Zitierstil (17. Ausg.)Kriegsmann, Katharina, Tilman Schöning, Mark-Alexander Schwarzbich, Martin Cremer, Tobias Dittrich, Anthony Dick Ho, und Mathias Witzens-Harig. Minimal Renal Toxicity After Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma. London; Berlin; Heidelberg: BioMed Central; Springer, 2016.
MLA-Zitierstil (9. Ausg.)Kriegsmann, Katharina, et al. Minimal Renal Toxicity After Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma. BioMed Central; Springer, 2016.